TDP-43 pathology disrupts ER-mitochondria contact sites (MAMs) via Mfn2/GRP75/VDAC1 mislocalization, causing dysregulated calcium transfer. Sustained mitochondrial Ca2+ loading—particularly combined with oxidative stress—exceeds buffering capacity and triggers CypD-dependent mPTP opening. This integrates TDP-43's known MAM disruption effects with the calcium-mPTP nexus, providing a mechanism that connects upstream TDP-43 stress to downstream mPTP priming.
**Background and Rationale** TREM2 variants represent major genetic risk factors for Alzheimer's disease, with loss-of-function mutations increasing dementia risk threefold. While TREM2 is exclusively expressed on microglia, emerging evidence suggests its primary pathogenic role occurs through disrupted astrocyte-microglia communication rather than intrinsic microglial dysfunction. Healthy brain homeostasis depends on coordinated responses between these glial populations, where TREM2+ microglia
Verdict Summary
1/10
dimensions won
MCU Calcium Overload via MFN2/GRP75/VDAC
9/10
dimensions won
TREM2-Dependent Astrocyte-Microglia Cros
Radar Chart — 10 Dimensions
Score Comparison Bars
Mechanistic
0.66
0.88
Evidence
0.62
0.80
Novelty
0.68
0.72
Feasibility
0.65
0.82
Impact
0.70
0.78
Druggability
0.58
0.65
Safety
0.55
0.58
Competition
0.72
0.70
Data
0.60
0.85
Reproducible
0.64
0.75
Score Breakdown
Dimension
MCU Calcium Overload via MFN2/
TREM2-Dependent Astrocyte-Micr
Mechanistic
0.660
0.880
Evidence
0.620
0.800
Novelty
0.680
0.720
Feasibility
0.650
0.820
Impact
0.700
0.780
Druggability
0.580
0.650
Safety
0.550
0.580
Competition
0.720
0.700
Data
0.600
0.850
Reproducible
0.640
0.750
Evidence
MCU Calcium Overload via MFN2/GRP75/VDAC1 MAM Dysfunction
No evidence citations yet
TREM2-Dependent Astrocyte-Microglia Cross-talk in Neurodegen
No evidence citations yet
Debate Excerpts
MCU Calcium Overload via MFN2/GRP75/VDAC1 MAM Dysf
Based on my research, I'll now generate novel therapeutic hypotheses focused on aging-related gene expression changes that predict neurodegenerative vulnerability. Here are 6 evidence-based therapeuti...
Skeptic
## Critical Evaluation of Therapeutic Hypotheses
I'll provide a rigorous critique of each hypothesis, identifying weaknesses and counter-evidence:
### 1. **AP1S1-Mediated Vesicular Transport Restora...
Domain Expert
# Practical Feasibility Assessment of Therapeutic Hypotheses
Based on my analysis of druggability, existing compounds, competitive landscape, and development considerations, here's my comprehensive a...
Synthesizer
Based on my synthesis of the Theorist's hypotheses, Skeptic's critiques, and Expert's feasibility assessment, here's the final JSON output:
```json
{
"ranked_hypotheses": [
{
"rank": 1,
...